convincing: in fact many workers consider it valueless.
Epoxides form a group of important compounds, since they participate in a number of industrial processes. They are biologically reactive and produce mutagenic changes in a number of biological systems. Unfortunately, the main evidence for their carcinogenic activity rests on repeated subcutaneous injection in rats and mice, and there are considerable reservations about the validity of this route for carcinogenicity testing. Comparatively few of the epoxides mentioned have been tested by other routes.
The miscellaneous chemicals considered are principally ones of importance from the point of view of industrial exposure. Some of these are indubitably carcinogenic to animals.
At the end of the book there is a small but interesting section on volatile anaesthetics. The Working Group responsible for this section found that the environment of the operating theatre presented some carcinogenic hazard, but were unable to impute this to volatile anaesthetics.
Like others in the series, this volume will be of considerable value to many scientists, and particularly to toxicologists, on whom the burden of evaluating the carcinogenic risk of chemicals to man so often falls. In many instances, the latter will have to rely on their own judgment with regard to the meaning of the animal data in terms of carcinogenic risk to man, since little assistance is given by the experts in this respect.
P For the remainder of the first chapter and most of the second (" Immunological Monitoring and Adjuvant Immunotherapy of Selected Cancer Patients") in which Dr Reif is joined by Dr C. W. Kaiser, the discussion is centred upon the foundation stone of tumour immunology: the antigenicity of experimental and human neoplasms. The treatment of the experimental data in summary form is reasonable enough, and Dr Reif eloquently draws out the basic distinctions between tumours of chemical and viral aetiology and discusses the concepts of antigenie strength and specificity. The picture of the current status of human tumour immunology is by contrast, disappointing. The limitation derives principally from a deceptively oversimplified treatment of the techniques which purport to demonstrate human tumour antigenicity in vitro. There is uncritical acceptance of the concept of histological tumour-type specificity, and the unwarrantable assumption that this antigen cross-reactivity is an indication of viral origin for some human tumours.
Chapter 3 (" Clinical Aspects of Cancer Immunotherapy ") by Dr G. Biano, gives a lucid and rational view of clinical immunotherapy, the justification for which is the limitation of the established modalities of chemotherapy and radiotherapy. The chapter consists of a statement of the problems which confront the w ould-be immunotherapist. In the main these are fundamental and a reflection of persisting ignorance of antigens which are expressed on human tumour cells and the types of immune response evoked by them. This is followed 
